Unprecedented alkaloid skeleton from the mediterranean sponge reniera sarai: X-ray structure of an acetate derivative of sarain-a

Antifungal and antibacterial activity of marine sponges from Ratnagiri coast of India

Marine sponges have proved to be a rich source of bioactive metabolites with multiple pharmacological properties. In this study, we have investigated the antifungal and antibacterial activities of methanol extracts of Cliona, Haliclona cratera, Hyrtios cavernosus, Spongia obscura, Sarcotragus foetidus, and Xestospongia carbonaria and fractions from X. carbonaria S. obscura and H. cratera. The antibacterial activity was determined by agar disc diffusion method against clinical gram-positive- Staphylococcus aureus, Bacillus subtilis and gram negative- Escherichia coli, Pseudomonas aeruginosa bacteria. The antifungal activity of the extracts and fractions was determined against Candida albicans and Aspergillus niger. S. obscura, X. carbonaria, H. cavernosus, and H. cratera exhibited good antibacterial activity against the tested gram-positive bacteria with larger zones of inhibition at 19±6 mm, 19.5±5.5mm, 20±0 mm and 23±0 mm. S. foetidus gave good inhibition of gram-negative bacteria at 19±0 mm. They showed moderate antifungal activities against C. albicans and A. niger. Cliona, H. cratera and H. cavernosus gave inhibition with 20±5 mm, 15.5±0.5 mm and 25.5±14.5 mm for A. niger. The MIC for Xc_PE_2, Sob_n but_1 and Hc_n but_3 was determined. H. cavernosus, S. foetidus, S. obscura and X. carbonaria showed presence of fatty acids and sterol type of compounds. The mass of molecular ions in purified fractions helped in characterization of known compounds in H. cratera, X. carbonaria and S. obscura which exhibited good antimicrobial activity.

Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents

The incidence of neurodegenerative diseases, such as Alzheimer's disease (AD), increases continuously demanding the urgent development of anti-Alzheimer's agents. Marine organisms (MO) have to create their own defenses due to the adverse environment where they live and so synthesize several classes of compounds, such as akaloids, to defend themselves. Therefore, the identification of marine natural products with neuroprotective effects is a necessity. Being that AD is not only a genetic but also an environmental complex disease, a treatment for AD remains to discover. As the major clinical indications (CI) of AD are extracellular plaques formed by β-amyloid (Aβ) protein, intracellular neurofibrillary tangles (NFTs) formed by hyper phosphorylated τ-protein, uncommon inflammatory response and neuron apoptosis and death caused by oxidative stress, alkaloids that may decrease CI, might be used against AD. Most of the alkalolids with those properties are derivatives of the amino acid tryptophan mainly with a planar indole scaffold. Certainly, alkaloids targeting more than one CI, multitarget-directed ligands (MTDL), have the potential to become a lead in AD treatment. Alkaloids to have a maximum of activity against CI, should be planar and contain halogens and amine quaternization.

Skipped dienes in natural product synthesis

Covering: 2000-2020The 1,4-diene motif, also known as a skipped diene, is widespread across various classes of natural products including alkaloids, fatty acids, terpenoids, and polyketides as part of either the finalized structure or a biosynthetic intermediate. The prevalence of this nonconjugated diene system in nature has resulted in numerous encounters in the total synthesis literature. However, skipped dienes have not been extensively reviewed, which could be attributed to overshadowing by the more recognized 1,3-diene system. In this review, we aim to highlight the relevance of skipped dienes in natural products through the lens of total synthesis. Subjects that will be covered include nomenclature, structural properties, prevalence in natural products, synthetic strategies and the future direction of the field.

Organocatalytic Asymmetric Synthesis of an Advanced Intermediate of (+)-Sarain A

The first organocatalytic asymmetric synthesis of an advanced intermediate of (+)-sarain A was achieved. This approach featured the employment of an organocatalytic asymmetric Michael addition reaction and a nitrogen-to-carbon chirality transfer to forge three chiral centers, as well as a catalytic hydrosilylation for the chemoselective reduction of a key lactam intermediate. The tricyclic intermediate contained all the required functionalities for elaborating into (+)-sarain A.

Recent progress on the total syntheses of macrocyclic diamine alkaloids

This review highlights the progress and challenges in the chemical synthesis of macrocyclic diamine alkaloids since 2006.

Natural cholinesterase inhibitors from marine organisms

Covering: Published between 1974 up to 2018Inhibition of cholinesterases is a common approach for the management of several disease states. Most notably, cholinesterase inhibitors are used to alleviate the symptoms of neurological disorders like dementia and Alzheimer's disease and treat myasthenia gravis and glaucoma. Historically, most drugs of natural origin have been isolated from terrestrial sources and inhibitors of cholinesterases are no exception. However, the last 50 years have seen a rise in the quantity of marine natural products with close to 25 000 reported in the scientific literature. A number of marine natural products with potent cholinesterase inhibitory properties have also been reported; isolated from a variety of marine sources from algae to ascidians. Representing a diverse range of structural classes, these compounds provide inspirational leads that could aid the development of therapeutics. The current paper aims to, for the first time, comprehensively summarize the literature pertaining to cholinesterase inhibitors derived from marine sources, including the first papers published in 1974 up to 2018. The review does not report bioactive extracts, only isolated compounds, and a specific focus lies on compounds with reported dose-response data. In vivo and mechanistic data is included for compounds where this is reported. In total 185 marine cholinesterase inhibitors and selected analogs have been identified and reported and some of the compounds display inhibitory activities comparable or superior to cholinesterase inhibitors in clinical use.

Application of (4+3) cycloaddition strategies in the synthesis of natural products

This review summarizes the applications of (4+3) cycloadditions, both classical and formal, in the syntheses of natural products in the last two decades.

Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells

Sarains are diamide alkaloids isolated from the Mediterranean sponge Haliclona (Rhizoniera) sarai that have previously shown antibacterial, insecticidal and anti-fouling activities. In this study, we examined for the first time the neuroprotective effects of sarains 1, 2 and A against oxidative stress in a human neuronal model. SH-SY5Y cells were co-incubated with sarains at concentrations ranging from 0.01 to 10 μM, and the well-known oxidant hydrogen peroxide at 150 μM for 6 h and the protective effects of the compounds were evaluated. Among the sarains tested, sarain A was the most promising compound, improving mitochondrial function and decreasing reactive oxygen species levels in human neuroblastoma cells treated with the compound at 0.01, 0.1 and 1 μM. This compound was also able to increase the activity of the antioxidant enzymes superoxide dismutases by inducing the translocation of the nuclear factor E2-related factor 2 (Nrf2) to the nucleus at the lower concentrations tested (0.01 and 0.1 μM). Moreover, sarain A at 0.1 and 1 μM blocked the mitochondrial permeability transition pore (mPTP) opening through cyclophilin D inhibition. These results suggest that the protective effects produced by the treatment with sarain A are related with its ability to block the mPTP and to enhance the Nrf2 pathway, indicating that sarain A may be a candidate compound for further studies in neurodegenerative diseases.

Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms

Continuous increases in the incidence of neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and brain stroke demand the urgent development of therapeutics. Marine organisms are well-known producers of natural products with diverse structures and pharmacological activities. Therefore, researchers have endeavored to identify marine natural products with neuroprotective effects. In this regard, this review summarizes therapeutic targets for AD, PD, and ischemic brain stroke and marine natural products with pharmacological activities on the targets according to taxonomies of marine organisms. Furthermore, several marine natural products on the clinical trials for the treatment of neurological disorders are discussed.

The Saraine Alkaloids

Saraines have been isolated by the group of Cimino from the marine sponge Reniera sarai collected in the Bay of Naples. These alkaloids can be classified into two categories, depending on the type of their structure. Saraines 1-3 and isosaraines 1-3 are characterized by a trans-2-oxoquinolizidine moiety bound directly to a tetrahydropyridine ring, both nuclei being also linked by two alkyl chains of different lengths. On the other hand, saraines A-C and misenine present a diazatricyclic central core, showing an unusual interaction between an aldehyde and a tertiary amine and giving them a zwitterionic character, and flanked with two chains forming macrocycles. In a first part of the chapter, the isolation, spectral data, and structure elucidation of saraines are presented. Biological properties and biogenetic proposals concerning these compounds are then described. The most important part is devoted to synthetic approaches and total synthesis of saraine A.

Sponge chemical diversity: from biosynthetic pathways to ecological roles

Since more than 50 years, sponges have raised the interest of natural product chemists due to the presence of structurally original secondary metabolites. While the main objective were first to discover new drugs from the Sea, a large number of interrogations arose along with the isolation and structure elucidations of a wide array of original architectures and new families of natural products not found in the terrestrial environment. In this chapter, we focus on the results obtained during this period on the following questions. A preliminary but still unresolved issue to be addressed will be linked to the role of the microbiota into the biosynthesis of these low-weight compounds. Our knowledge on the biosynthetic pathways leading to plant secondary metabolites is now well established, and this background will influence our comprehension of the biosynthetic events occurring in a sponge. But is the level of similarity between both metabolisms so important? We clearly need more experimental data to better assess this issue. This question is of fundamental interest because sponges have a long evolutionary history, and this will allow a better understanding on the transfer of the genetic information corresponding to the biosynthesis of secondary metabolites. After the how, the why! The question of the ecological role of these metabolites is also of high importance first not only because they can serve as synapomorphic characters but also because they may represent chemical cues in the water environment. Even if most of these compounds are considered as defensive weapons for these sessile invertebrates, they may also be linked to physiological characters as the reproduction. Finally, a metabolomic approach can appear as a complementary tool to give additional information on the sponge fitness. All the new developments in molecular biology and bioanalytical tools will open the way for a better comprehension on the complex field of sponge secondary metabolites.

(4+3) cycloaddition reactions of nitrogen-stabilized oxyallyl cations

The use of heteroatom-substituted oxyallyl cations in (4+3) cycloadditions has had a tremendous impact on the development of cycloaddition chemistry. Extensive efforts have been exerted toward investigating the effect of oxygen, sulfur, and halogen substituents on the reactivity of oxyallyl cations. Most recently, the use of nitrogen-stabilized oxyallyl cations has gained prominence in the area of (4+3) cycloadditions. The following article will provide an overview of this concept utilizing nitrogen-stabilized oxyallyl cations.

Construction of an advanced tetracyclic intermediate for total synthesis of the marine alkaloid sarain A

In work directed toward a total synthesis of the marine alkaloid sarain A (1), the advanced intermediate 54, containing all the key elements and the seven stereogenic centers of sarain A, has been successfully synthesized from bicyclic lactam 4, previously prepared via an intramolecular stereospecific [3 + 2]-azomethine ylide dipolar cycloaddition. Intermediate lactam 4 could be efficiently converted to N-Boc derivative 12. Introduction of a two-carbon fragment into lactam 12 which eventually becomes the C-7',8' syn diol of the "eastern" ring was then achieved by C-acylation of the corresponding enolate with methoxyacetyl chloride followed by a highly stereoselective ketone reduction with Zn(BH4)2 to afford alcohol 16. Intermediate 16 has the incorrect C-7' relative stereochemistry for sarain A, but this problem was conveniently remedied by inverting the C-7' center via an intramolecular Ohfune-type cyclization of the silyl carbamate derived from Boc mesylate 27 to produce the key cyclic carbamate 28. It was then possible to convert acetal 28 to allylsilane 32 followed by cyclization to the alkaloid tricyclic core 33 via an allylsilane/N-sulfonyliminium ion cyclization. Formation of the "western" macrocyclic ring has been successfully addressed using functional group handles at C-3' and N-1' on the tricyclic core via a ring-closing olefin metathesis (RCM) strategy with the second-generation Grubbs ruthenium catalyst to produce intermediate macrolactam 47. A chelation-controlled addition of ethynylmagnesium bromide to advanced aldehyde 51 afforded a single diastereomeric adduct 53 which is tentatively assigned to have the correct C-7',8' syn-diol stereochemistry. This adduct could be rearranged to the conveniently protected amino carbonate 54 which is set up for construction of the remainder of the eastern ring of sarain A.

Synthetic studies toward sarain A. Formation of the western macrocyclic ring

Starting with the tricyclic core 2b, annulation to form the 13-membered western ring of sarain A has been achieved to afford the macrocycle 30a by initial construction of the sterically congested quaternary center at C-3, followed by elaboration of the C-3 side-chain and ring-closing olefin metathesis. Also included is a parallel conversion of tricycle 2c to macrocycle 30b containing a functionalized side-chain at N-1 suitable for attachment of the eastern macrocyclic ring.

Facile synthesis of the tricyclic core of sarain A. 3-Oxidopyridinium betaine cycloaddition approach

[formula: see text] A new approach to a suitably functionalized tricyclic core of sarains has been developed by means of Katritzky's cycloaddition using 3-oxidopyridinium betaines. A key step was the regioselective differentiation of the two nearly identical hydroxy groups derived from oxidative cleavage of the double bond in 8 to afford 14. A stereocontrolled construction of the tricyclic core 20 of sarains containing the requisite side chain at C-3' was achieved by an intramolecular conjugate addition.